Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
November 9, 2017
Galmed Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
TEL AVIV, Israel, Nov. 9, 2017 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of a once-daily, ...
November 9, 2017
CytoSorbents Recognized on Deloitte's 2017 Technology Fast 500™ as One of the Fastest Growing Companies in North America
MONMOUTH JUNCTION, N.J., Nov. 9, 2017 /PRNewswire/ -- CytoSorbents Corporation (CTSO) announced that at last evening's awards ceremony, it ranked 7th amongst 21 medical device companies, ...
November 9, 2017
New Peer Reviewed Publication Shows That BrainStorm's NurOwn® Has a Unique miRNA Signature
HACKENSACK, N.J. and PETACH TIKVAH, Israel, Nov. 9, 2017 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced ...
November 9, 2017
Eiger BioPharmaceuticals Reports Third Quarter 2017 Financial Results
PALO ALTO, Calif., Nov. 9, 2017 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today ...
November 9, 2017
Albireo to Present at the Jefferies 2017 London Healthcare Conference
BOSTON, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
November 9, 2017
iCAD Announces Positive Clinical Data on Xoft System for Non-Melanoma Skin Cancer Treatment Selected as “Best of ASTRO 2017”
NASHUA, N.H. and MIAMI, Nov. 09, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today ...
November 9, 2017
VBL Therapeutics to Present at the 22nd Annual Scientific Meeting of the Society for Neuro-Oncology (SNO) on November 18
TEL AVIV, Israel, Nov. 09, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class ...
November 9, 2017
Advaxis to Present at the Jefferies 2017 London Healthcare Conference
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announces that company management will participate in ...
November 9, 2017
Prometic to Report its Third Quarter 2017 Financial Results and to Hold Conference Call / Webcast
LAVAL, QC, Nov. 9, 2017 /PRNewswire/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) ("Prometic") today announced that it will report its financial results for the ...
November 9, 2017
UroGen Pharma to Present at the Jefferies 2017 London Healthcare Conference
RA’ANANA, Israel and NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
November 9, 2017
ADMA Biologics Announces Pricing of Follow-On Offering
RAMSEY, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company ...
November 9, 2017
Rexahn Pharmaceuticals to Present at the Stifel 2017 Healthcare Conference
ROCKVILLE, Md., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, ...
November 9, 2017
Ignyta to Present at the Jefferies 2017 London Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jacob Chacko, M.D., its Chief Financial Officer, will make ...
November 9, 2017
STRATA Skin Sciences Reports Third Quarter 2017 Financial Results
HORSHAM, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- (SSKN) STRATA Skin Sciences, Inc. (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to ...
November 9, 2017
Altimmune Announces Third Quarter 2017 Financial Results and Provides Corporate Update
GAITHERSBURG, Md., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced financial results for the three- and nine-months ended ...
November 9, 2017
BioDelivery Sciences Reports Third Quarter 2017 Financial Results and Provides Corporate Update
RALEIGH, N.C., Nov. 9, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) today reported financial results for the three and nine months ended September 30, 2017, ...
November 9, 2017
BioTime Reports Third Quarter Results and Recent Corporate Accomplishments
ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE American: BTX), a late stage clinical biotechnology company developing and commercializing products addressing degenerative diseases, today reported financial results for ...
November 9, 2017
CorMedix Inc. Reports Third Quarter Financial Results and Provides Business Update
BERKELEY HEIGHTS, NJ / ACCESSWIRE / November 9, 2017 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products ...
November 9, 2017
CytoSorbents Continues Strong Trajectory of Growth in the Third Quarter 2017
MONMOUTH JUNCTION, N.J., Nov. 9, 2017 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader using blood purification to prevent or treat life-threatening injury and ...
November 8, 2017
VALNEVA Signs $39.6 Million IXIARO® Supply Contract with US Government
Valneva SE ("Valneva" or "the Company"),  a fully integrated, commercial stage biotech company focused on developing innovative, life-saving vaccines, announces today the signing of a ...
Page 78 of 117